Zealand Pharma A/S (CPH:ZEAL)
211.40
-1.30 (-0.61%)
Nov 20, 2026, 11:00 AM CET
Zealand Pharma Stock Forecast
Stock Price Forecast
According to 16 analysts polled by S&P Global, Zealand Pharma stock has a consensus rating of "Buy" and an average price target of krĀ 383.58. The average 1-year stock price forecast is 81.45% higher than the current stock price, while the lowest is krĀ 280.00 (+32.45%) and the highest is krĀ 550.00 (+160.17%).
Price Target: krĀ 383.58 (+81.45%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Zealand Pharma stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 5 | 5 | 5 | 5 | 5 |
| Buy | 3 | 3 | 3 | 2 | 1 | 1 |
| Hold | 7 | 8 | 8 | 8 | 9 | 9 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 17 | 17 | 17 | 16 | 16 | 16 |
Financial Forecast
Revenue This Year
4.55B
from 9.21B
Decreased by -50.67%
Revenue Next Year
4.23B
from 4.55B
Decreased by -6.86%
EPS This Year
37.13
from 90.22
Decreased by -58.85%
EPS Next Year
6.93
from 37.13
Decreased by -81.35%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is DKK.